Ryan Z. Turncliff, Ph.D. - Publications

Affiliations: 
2004 University of North Carolina, Chapel Hill, Chapel Hill, NC 
Area:
Pharmacy, Pharmacology, Cell Biology

14 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2012 Dean RL, Eyerman D, Todtenkopf MS, Turncliff RZ, Bidlack JM, Deaver DR. Effects of oral loperamide on efficacy of naltrexone, baclofen and AM-251 in blocking ethanol self-administration in rats. Pharmacology, Biochemistry, and Behavior. 100: 530-7. PMID 22056608 DOI: 10.1016/j.pbb.2011.10.019  0.48
2009 Todtenkopf MS, O'Neill KS, Kriksciukaite K, Turncliff RZ, Dean RL, Ostrovsky-Day I, Deaver DR. Route of administration affects the ability of naltrexone to reduce amphetamine-potentiated brain stimulation reward in rats. Addiction Biology. 14: 408-18. PMID 19489752 DOI: 10.1111/j.1369-1600.2009.00161.x  0.48
2007 Dunbar JL, Turncliff RZ, Hayes SC, Farrell CB. Population pharmacokinetics of extended-release injectable naltrexone (XR-NTX) in patients with alcohol dependence. Journal of Studies On Alcohol and Drugs. 68: 862-70. PMID 17960304  0.48
2006 Turncliff RZ, Hoffmaster KA, Kalvass JC, Pollack GM, Brouwer KL. Hepatobiliary disposition of a drug/metabolite pair: Comprehensive pharmacokinetic modeling in sandwich-cultured rat hepatocytes. The Journal of Pharmacology and Experimental Therapeutics. 318: 881-9. PMID 16690724 DOI: 10.1124/jpet.106.102616  0.48
2006 Turncliff RZ, Tian X, Brouwer KL. Effect of culture conditions on the expression and function of Bsep, Mrp2, and Mdr1a/b in sandwich-cultured rat hepatocytes. Biochemical Pharmacology. 71: 1520-9. PMID 16542640 DOI: 10.1016/j.bcp.2006.02.004  0.48
2006 Dunbar JL, Turncliff RZ, Dong Q, Silverman BL, Ehrich EW, Lasseter KC. Single- and multiple-dose pharmacokinetics of long-acting injectable naltrexone. Alcoholism, Clinical and Experimental Research. 30: 480-90. PMID 16499489 DOI: 10.1111/j.1530-0277.2006.00052.x  0.48
2005 Turncliff RZ, Dunbar JL, Dong Q, Silverman BL, Ehrich EW, Dilzer SC, Lasseter KC. Pharmacokinetics of long-acting naltrexone in subjects with mild to moderate hepatic impairment. Journal of Clinical Pharmacology. 45: 1259-67. PMID 16239359 DOI: 10.1177/0091270005280199  0.48
2004 Hoffmaster KA, Turncliff RZ, LeCluyse EL, Kim RB, Meier PJ, Brouwer KL. P-glycoprotein expression, localization, and function in sandwich-cultured primary rat and human hepatocytes: relevance to the hepatobiliary disposition of a model opioid peptide. Pharmaceutical Research. 21: 1294-302. PMID 15290872 DOI: 10.1023/B:PHAM.0000033018.97745.0d  0.48
2004 Turncliff RZ, Meier PJ, Brouwer KL. Effect of dexamethasone treatment on the expression and function of transport proteins in sandwich-cultured rat hepatocytes. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 32: 834-9. PMID 15258109 DOI: 10.1124/dmd.32.8.834  0.48
2003 Zamek-Gliszczynski MJ, Xiong H, Patel NJ, Turncliff RZ, Pollack GM, Brouwer KL. Pharmacokinetics of 5 (and 6)-carboxy-2',7'-dichlorofluorescein and its diacetate promoiety in the liver. The Journal of Pharmacology and Experimental Therapeutics. 304: 801-9. PMID 12538836 DOI: 10.1124/jpet.102.044107  0.48
2001 Annaert PP, Turncliff RZ, Booth CL, Thakker DR, Brouwer KL. P-glycoprotein-mediated in vitro biliary excretion in sandwich-cultured rat hepatocytes. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 29: 1277-83. PMID 11560870  0.48
2000 Aweeka F, Jayesekara D, Horton M, Swan S, Lambrecht L, Wilner KD, Sherwood J, Anziano RJ, Smolarek TA, Turncliff RZ. The pharmacokinetics of ziprasidone in subjects with normal and impaired renal function British Journal of Clinical Pharmacology. 49. PMID 10771451  0.48
2000 Everson G, Lasseter KC, Anderson KE, Bauer LA, Carithens RL, Wilner KD, Johnson A, Anziano RJ, Smolarek TA, Turncliff RZ. The pharmacokinetics of ziprasidone in subjects with normal and impaired hepatic function. British Journal of Clinical Pharmacology. 49: 21S-26S. PMID 10771450  0.48
2000 Wilner KD, Tensfeldt TG, Baris B, Smolarek TA, Turncliff RZ, Colburn WA, Hansen RA. Single- and multiple-dose pharmacokinetics of ziprasidone in healthy young and elderly volunteers British Journal of Clinical Pharmacology. 49. PMID 10771449  0.48
Show low-probability matches.